# Somaxon Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/somaxon-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.somaxon.com
- Total disclosed funding: $88M
- Latest round: Series C (Jun 6, 2005)
- Investors on record: 8

## About

Somaxon Pharmaceuticals Inc. is based in the US and operates as a specialty pharmaceutical company, with a particular focus on the treatment of diseases and disorders in the central nervous system therapeutic area.

## Funding rounds

- Series C, Jun 6, 2005, $65M — Domain Associates, Prospect Venture Partners, Montreux Equity Partners, Scale Venture Partners, CDIB BioScience Venture Management, MPM BioImpact
- Series B, Jun 15, 2004, $23M — Domain Associates, Montreux Equity Partners, Windamere Venture Partners, Scale Venture Partners, CDIB BioScience Venture Management, Fog City Capital

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B, Series C
- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series B
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series B, Series C
- CDIB BioScience Venture Management (https://capitalatlas.ai/funds/cdib-bioscience-venture-management) — Series B, Series C
- Fog City Capital (https://capitalatlas.ai/funds/fog-city-capital) — Series B
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series C
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C